NASDAQ:SIGA - Nasdaq - US8269171067 - Common Stock - Currency: USD
Taking everything into account, SIGA scores 8 out of 10 in our fundamental rating. SIGA was compared to 194 industry peers in the Pharmaceuticals industry. SIGA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. SIGA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make SIGA suitable for value and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 19.64% | ||
ROE | 22.45% | ||
ROIC | 20% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 46.91% | ||
PM (TTM) | 40.33% | ||
GM | 76.55% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 11.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 8.4 | ||
Quick Ratio | 6.28 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.1 | ||
Fwd PE | 3.93 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 7.82 | ||
EV/EBITDA | 5.8 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 8.86% |
6.77
-0.13 (-1.88%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 8.86% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.1 | ||
Fwd PE | 3.93 | ||
P/S | 4.02 | ||
P/FCF | 7.82 | ||
P/OCF | 7.81 | ||
P/B | 2.24 | ||
P/tB | 2.25 | ||
EV/EBITDA | 5.8 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 19.64% | ||
ROE | 22.45% | ||
ROCE | 25.75% | ||
ROIC | 20% | ||
ROICexc | 76.95% | ||
ROICexgc | 78.19% | ||
OM | 46.91% | ||
PM (TTM) | 40.33% | ||
GM | 76.55% | ||
FCFM | 51.42% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 12.59% | ||
Cap/Sales | 0.06% | ||
Interest Coverage | 250 | ||
Cash Conversion | 108.69% | ||
Profit Quality | 127.5% | ||
Current Ratio | 8.4 | ||
Quick Ratio | 6.28 | ||
Altman-Z | 11.67 |